Flputnam Investment Management Co. Buys Shares of 142,608 Enovix Corporation $ENVX

Posted by Brian Himes on Aug 18th, 2026

Flputnam Investment Management Co. purchased a new stake in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 142,608 shares of the company’s stock, valued at approximately $866,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Enovix by 5.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock valued at $722,000 after buying an additional 4,780 shares during the period. NewEdge Advisors LLC boosted its position in Enovix by 10.4% during the 1st quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock worth $193,000 after buying an additional 2,481 shares during the period. Goldman Sachs Group Inc. boosted its position in Enovix by 65.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock worth $8,351,000 after buying an additional 449,934 shares during the period. Caxton Associates LLP bought a new stake in Enovix during the 1st quarter worth approximately $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Enovix by 18.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock worth $2,628,000 after acquiring an additional 55,676 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ENVX has been the subject of several analyst reports. Bank of America reaffirmed a “neutral” rating and set a $5.00 price target on shares of Enovix in a research note on Monday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $25.00 target price on shares of Enovix in a report on Thursday, August 13th. Benchmark dropped their price target on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Finally, Craig Hallum set a $7.00 target price on shares of Enovix in a report on Thursday. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $11.77.

Get Our Latest Stock Analysis on ENVX

Enovix Stock Down 18.0%

Shares of NASDAQ ENVX opened at $3.60 on Tuesday. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The company has a 50-day moving average price of $5.26 and a 200-day moving average price of $5.83. The stock has a market capitalization of $785.34 million, a P/E ratio of -4.44 and a beta of 2.32. Enovix Corporation has a 1 year low of $3.52 and a 1 year high of $14.21.

Enovix (NASDAQ:ENVX – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The company had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. During the same quarter in the prior year, the business posted ($0.13) EPS. The firm’s revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts forecast that Enovix Corporation will post -0.78 EPS for the current fiscal year.

More Enovix News

Here are the key news stories impacting Enovix this week:

Positive Sentiment: Northland Securities reiterated a Buy rating on Enovix, providing continued analyst support for the battery developer. Enovix Receives a Buy from Northland Securities
Positive Sentiment: B. Riley Securities also issued a Buy rating, which may help support the stock despite broader concerns about execution and profitability. Enovix Receives a Buy from B. Riley Securities
Positive Sentiment: A report highlighted Enovix’s efforts to advance next-generation battery manufacturing, potentially reinforcing the long-term production and commercialization story. Enovix Steps Up Next-Generation Battery Manufacturing Push
Neutral Sentiment: Traders purchased 20,888 ENVX call options, about 29% above average daily call volume. The activity may signal speculative bullish interest, but options volume alone does not confirm a sustained stock rally.
Negative Sentiment: Enovix announced a CEO transition and search for a successor. Leadership uncertainty can weigh on investor confidence while the company works to scale manufacturing and improve financial results. Enovix Announces CEO Transition and Search
Negative Sentiment: William Blair downgraded Enovix from Outperform to Market Perform, reducing a source of analyst support and likely contributing to the stock’s weakness.

Enovix Company Profile

(Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.